Low patient adherence and unmanaged side effects pose a significant problem for healthcare systems the world over. How do you ensure patients take their medicine in the right way, at the right time, time after time? How do you indentify potential side effects and instruct patients early enough to avoid treatment issues? Mass has developed patient adherence programmes for a number of orphan drugs which have seen good success in overcoming barriers to compliance.
These programmes combine patient education and adherence support tools with a personalised nurse support service. This multi-discipline approach helps empower patients with the knowledge of why they should stick to their prescribed treatment and the belief in their ability to take control of their health. Enhanced patient adherence is good news all round, as optimal patient outcomes, improved physician-patient communication and more cost-effective care benefits both patients and clinicians, as well as fosters brand loyalty for the drug